Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimeras (Q48312537)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 January 2018

Language	Label	Description	Also known as
English	Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimeras	scientific article published on 3 January 2018

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/29299660

Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimeras (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/29299660

Isabelle Dierckx de Casterlé

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Sabine Fevery

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Omer Rutgeerts

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Fariba Poosti

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sofie Struyf

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Caroline Lenaerts

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Mark Waer

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

An D Billiau

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

3 January 2018

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/29299660

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

67

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

589-603

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Allogeneic or haploidentical HSCT for refractory or relapsed solid tumors in children: toward a neuroblastoma model

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Cellular therapy following allogeneic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Mechanisms of the antitumor responses and host-versus-graft reactions induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: a critical role for recipient CD4+ T cells and recipient leukocyte infusion

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Invariant NKT cells are required for antitumor responses induced by host-versus-graft responses

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Recipient lymphocyte infusion in MHC-matched bone marrow chimeras induces a limited lymphohematopoietic host-versus-graft reactivity but a significant antileukemic effect mediated by CD8+ T cells and natural killer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Recipient leukocyte infusion enhances the local and systemic graft-versus-neuroblastoma effect of allogeneic bone marrow transplantation in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Current and future strategies for relapsed neuroblastoma: challenges on the road to precision therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Improved antitumour immunity in murine neuroblastoma using a combination of IL-2 and IL-12.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Transient expansion of Mac1+Ly6-G+Ly6-C+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Immunogenicity of human neuroblastoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

5-Fluorouracil: mechanisms of action and clinical strategies

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Polyphenon [corrected] E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Myeloid-derived suppressor cells: linking inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

The immunobiology of myeloid-derived suppressor cells in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Improving cancer immunotherapy by targeting tumor-induced immune suppression

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Cancer immunotherapy: the beginning of the end of cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2114-8

21 January 2018

Identifiers

10.1007/S00262-017-2114-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29299660%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48312537&oldid=2209317088"